References
- Calado RT, Young NS. Telomere diseases. N Engl J Med. 2009;361:2353–65.
- Walne AJ, Dokal I. Advances in the understanding of dyskeratosis congenita. Br J Haematol. 2009;145:164–72.
- Parry EM, Alder JK, Qi X, Chen JJ, Armanios M. Syndrome complex of bone marrow failure and pulmonary fibrosis predicts germline defects in telomerase. Blood. 2011;117:5607–11.
- Calado RT, Brudno J, Mehta P, Kovacs JJ, Wu C, Zago MA, et al.. Constitutional telomerase mutations are genetic risk factors for cirrhosis. Hepatology. 2011;53:1600–7.
- Hartmann D, Srivastava U, Thaler M, Kleinhans KN, N’kontchou G, Scheffold A, et al.. Telomerase gene mutations are associated with cirrhosis formation. Hepatology. 2011;53:1608–17.
- Alter BP, Baerlocher GM, Savage SA, Chanock SJ, Weksler BB, Willner JP, et al.. Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. Blood. 2007;110:1439–47.
- Scheinberg P, Cooper JN, Sloand EM, Wu CO, Calado RT, Yound NS. Association of telomere length of peripheral blood leukocytes predicts hematopoietic relapse, malignant transformation, and survival in severe aplastic anemia. JAMA. 2010;304:1358–64.
- Calado RT, Cooper JN, Padilla-Nash HM, Sloand EM, Wu CO, Scheinberg P, et al.. Short telomeres result in chromosomal instability in hematopoietic cells and precede malignant evolution in human aplastic anemia. Leukemia. In press 2012.
- Calado RT, Regal JA, Hills M, Yewdell WT, Dalmazzo LF, Zago MA, et al.. Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia. Proc Nat Acad Sci USA. 2009;106:1187–92.
- Willeit P, Willeit J, Mayr A, Weger S, Oberhollenzer F, Brandstätter A, et al.. Telomere length and risk of incident cancer and cancer mortality. JAMA. 2010;304:69–75.
- Calado RT, Yewdell WT, Wilkerson KL, Regal JA, Kajigaya S, Stratakis CA, et al.. Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells. Blood. 2009;114:2236–43.